Kris MG - Search Results

1

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma.

Miller VA, Ng KK, Krug LM, Perez W, Pizzo B, Heelan RT, Kris MG. Miller VA, et al. Among authors: kris mg. Cancer. 2000 Mar 1;88(5):1045-50. doi: 10.1002/(sici)1097-0142(20000301)88:5<1045::aid-cncr14>3.0.co;2-j. Cancer. 2000. PMID: 10699893 Clinical Trial.

2

Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients.

Grant SC, Gralla RJ, Kris MG, Orazem J, Kitsis EA. Grant SC, et al. Among authors: kris mg. J Clin Oncol. 1992 Mar;10(3):484-98. doi: 10.1200/JCO.1992.10.3.484. J Clin Oncol. 1992. PMID: 1311028

3

Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.

Kris MG, Tyson LB, Clark RA, Gralla RJ. Kris MG, et al. Cancer. 1992 Aug 15;70(4 Suppl):1012-6. Cancer. 1992. PMID: 1386282 Review.

4

Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide.

Rigas JR, Tong WP, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: kris mg. Cancer Res. 1992 Dec 1;52(23):6619-23. Cancer Res. 1992. PMID: 1423306 Clinical Trial.

5

Limited small-cell lung cancer: do favorable short-term results predict ultimate outcome?

Armstrong J, Shank B, Scher H, Gaynor J, Martini N, Kutcher J, Kris M. Armstrong J, et al. Am J Clin Oncol. 1991 Aug;14(4):285-90. Am J Clin Oncol. 1991. PMID: 1650527

6

Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancer.

Rigas JR, Kris MG, Gralla RJ, Heelan RT, Marks LD. Rigas JR, et al. Among authors: kris mg. Invest New Drugs. 1991 May;9(2):187-90. doi: 10.1007/BF00175087. Invest New Drugs. 1991. PMID: 1651908 Clinical Trial.

7

Twice daily thoracic irradiation for limited small cell lung cancer.

Armstrong JG, Rosenstein MM, Kris MG, Shank BM, Scher HI, Fass DE, Harrison LB, Leibel SA, Fuks ZY. Armstrong JG, et al. Among authors: kris mg. Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1269-74. doi: 10.1016/0360-3016(91)90285-c. Int J Radiat Oncol Biol Phys. 1991. PMID: 1657842 Clinical Trial.

8

Limited small cell lung cancer: prognostic significance of a complete response to the induction phase of chemotherapy followed by thoracic irradiation.

Armstrong JG, Rosenstein MM, Scher HI, Fass DE, Zelefsky MJ, Kris MG. Armstrong JG, et al. Among authors: kris mg. Radiology. 1991 Mar;178(3):875-8. doi: 10.1148/radiology.178.3.1847240. Radiology. 1991. PMID: 1847240 Clinical Trial.

9

Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.

Berger MZ, Kris MG, Gralla RJ, Marks LD, Potanovich LM, Dimaggio JJ, Heelan RT. Berger MZ, et al. Among authors: kris mg. Am J Clin Oncol. 1991 Apr;14(2):124-6. doi: 10.1097/00000421-199104000-00006. Am J Clin Oncol. 1991. PMID: 1851387

10

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma.

Divgi CR, Welt S, Kris M, Real FX, Yeh SD, Gralla R, Merchant B, Schweighart S, Unger M, Larson SM, et al. Divgi CR, et al. J Natl Cancer Inst. 1991 Jan 16;83(2):97-104. doi: 10.1093/jnci/83.2.97. J Natl Cancer Inst. 1991. PMID: 1988695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters